The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

Nikki Laine has been taking the weight-loss drug Mounjaro for just over three weeks and has described it as "life-changing" ...

Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a near-total absence of ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...